After vaccination with the Russian peptide vaccine EpiVakKorona, antibodies to coronavirus are produced in more than 90% of those vaccinated, said Alexander Ryzhikov, head of the zoonotic infections and influenza department of the Vector State Scientific Center. He referred to studies among immunized groups.
“Independent studies show that, realistically, a high proportion of the population responds to vaccination. Among the volunteers, we revealed these figures, now we are conducting random studies among immunized groups, we see that these figures are significantly more than 90%, “Ryzhikov said on the Instagram account of Rospotrebnadzor.
He added that clinical trials of phase I-II of three-fold vaccination with EpiVacCorona are underway.
Anti-COVID19 vaccination continues in all regions of Russia. EpiVakKorona, developed in Vector, was the second vaccine against coronavirus to be registered in Russia.
